As an add-on treatment to behavioural therapy for tobacco dependence, anodal transcranial
direct current stimulation (tDCS) significantly increases the cessation rate compared to
treatment with sham tDCS; endpoint analysis will be performed 1, 3, 6 and 12 months after
completion of the smoke-free programme in combination with tDCS.
Craving, assessed with a visual analog scale (VAS), is reduced significantly in the verum
treatment group compared to the sham tDCS group.
tDCS is suitable for use in larger groups (8-12 people).